Real‐world EGFR testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional study

BACKGROUND: Before tyrosine kinase inhibitor (TKI) therapy can be administered in patients with advanced non‐small cell lung cancer (NSCLC), EGFR mutation testing is required. However, few studies have evaluated the extent of EGFR testing in real‐world practice in China. METHODS: A multicenter, obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ying, Wang, Yan, Zhao, Jun, Liu, Yunpeng, Gao, Hongjun, Ma, Kewei, Zhang, Shucai, Xin, Hua, Liu, Jiwei, Han, Chengbo, Zhu, Zhitu, Chen, Jun, Wen, Fugang, Li, Junling, Zhang, Jie, Zheng, Zhendong, Dai, Zhaoxia, Piao, Hongmei, Li, Xiaoling, Li, Yinyin, Zhong, Min, Ma, Rui, Zhuang, Yongzhi, Xu, Yuqing, Qu, Zhuohui, Yang, Haibo, Pan, Chunxia, Yang, Fan, Zhang, Daxin, Li, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209800/
https://www.ncbi.nlm.nih.gov/pubmed/30253083
http://dx.doi.org/10.1111/1759-7714.12859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209800/
https://www.ncbi.nlm.nih.gov/pubmed/30253083
http://dx.doi.org/10.1111/1759-7714.12859

Ejemplares similares